Skip to main content
Erschienen in: Abdominal Radiology 1/2019

02.07.2018

MR texture analysis: potential imaging biomarker for predicting the chemotherapeutic response of patients with colorectal liver metastases

verfasst von: Huan Zhang, Wenhua Li, Feixiang Hu, Yiqun Sun, Tingdan Hu, Tong Tong

Erschienen in: Abdominal Radiology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of the study was to determine whether the pre-treated MR texture features of colorectal liver metastases (CRLMs) are predictive of therapeutic response after chemotherapy.

Methods

The study included twenty-six consecutive patients (a total of 193 liver metastasis) with unrespectable CRLMs at our institution from August 2014 to February 2016. Lesions were categorized into either responding group or non-responding group according to changes in size. Texture analysis was quantified on T2-weighted images by two radiologists with consensus on regions of interest which were manually drawn on the largest cross-sectional area of the lesions. Five histogram features (mean, variance, skewness, kurtosis, and entropy1) and five gray level co-occurrence matrix features (GLCM; angular second moment (ASM), entropy2, contrast, correlation, and inverse difference moment (IDM)) were extracted. The texture parameters were statistically analyzed to identify the differences between the two groups, and the potential predictive parameters to differentiate the responding group from the non-responding group were subsequently tested using multivariable logistic regression analysis.

Results

A total of 107 responding and 86 non-responding lesions were evaluated. A higher variance, entropy1, contrast, entropy2 and a lower ASM, correlation, IDM were independently (P < 0.05) associated with a good response to chemotherapy with the areas under the ROC curves (AUCs) of 0.602–0.784. Variance (P < 0.001) and ASM (P = 0.001) remained potential predictive values to discriminate responding lesions from non-responding lesions when tested using multivariable logistic regression analysis. The highest AUC of the predictors from the association of variance and ASM was 0.814.

Conclusion

MR texture features on pre-treated T2 images have the potential to predict the therapeutic response of colorectal liver metastases.
Literatur
1.
Zurück zum Zitat Torre LA, Bray F, Siegel RL, et al. (2015) Global cancer statistics, 2012. CA 65:87–108PubMed Torre LA, Bray F, Siegel RL, et al. (2015) Global cancer statistics, 2012. CA 65:87–108PubMed
2.
Zurück zum Zitat Kemeny N (2006) Management of liver metastases from colorectal cancer. Oncology (Williston Park) 20:1185–1186 Kemeny N (2006) Management of liver metastases from colorectal cancer. Oncology (Williston Park) 20:1185–1186
3.
Zurück zum Zitat Leporrier J, Maurel J, Chiche L, et al. (2006) A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93:465–474CrossRef Leporrier J, Maurel J, Chiche L, et al. (2006) A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93:465–474CrossRef
4.
Zurück zum Zitat Asselin M, O’Connor JPB, Boellaard R, Thacker NA, Jackson A (2012) Quantifying heterogeneity in human tumours using MRI and PET. Eur J Cancer 48:447–455CrossRef Asselin M, O’Connor JPB, Boellaard R, Thacker NA, Jackson A (2012) Quantifying heterogeneity in human tumours using MRI and PET. Eur J Cancer 48:447–455CrossRef
5.
Zurück zum Zitat Cook GJR, Yip C, Siddique M, et al. (2013) Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy? J Nucl Med 54:19–26CrossRef Cook GJR, Yip C, Siddique M, et al. (2013) Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy? J Nucl Med 54:19–26CrossRef
6.
Zurück zum Zitat Liu J, Mao Y, Li Z, et al. (2016) Use of texture analysis based on contrast-enhanced MRI to predict treatment response to chemoradiotherapy in nasopharyngeal carcinoma. J Magn Reson Imaging 44:445–455CrossRef Liu J, Mao Y, Li Z, et al. (2016) Use of texture analysis based on contrast-enhanced MRI to predict treatment response to chemoradiotherapy in nasopharyngeal carcinoma. J Magn Reson Imaging 44:445–455CrossRef
7.
Zurück zum Zitat Michoux N, Van den Broeck S, Lacoste L, et al. (2015) Texture analysis on MR images helps predicting non-response to NAC in breast cancer. BMC Cancer 15:574CrossRef Michoux N, Van den Broeck S, Lacoste L, et al. (2015) Texture analysis on MR images helps predicting non-response to NAC in breast cancer. BMC Cancer 15:574CrossRef
8.
Zurück zum Zitat De Cecco CN, Ganeshan B, Ciolina M, et al. (2015) Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance. Investig Radiol 50:239–245CrossRef De Cecco CN, Ganeshan B, Ciolina M, et al. (2015) Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance. Investig Radiol 50:239–245CrossRef
9.
Zurück zum Zitat De Cecco CN, Ciolina M, Caruso D, et al. (2016) Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3T MR: initial experience. Abdom Radiol 41:1728–1735CrossRef De Cecco CN, Ciolina M, Caruso D, et al. (2016) Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3T MR: initial experience. Abdom Radiol 41:1728–1735CrossRef
10.
Zurück zum Zitat Miles KA, Ganeshan B, Griffiths MR, Young RCD, Chatwin CR (2009) Colorectal cancer: texture analysis of portal phase hepatic CT images as a potential marker of survival. Radiology 250:444–452CrossRef Miles KA, Ganeshan B, Griffiths MR, Young RCD, Chatwin CR (2009) Colorectal cancer: texture analysis of portal phase hepatic CT images as a potential marker of survival. Radiology 250:444–452CrossRef
11.
Zurück zum Zitat Lubner MG, Stabo N, Lubner SJ, et al. (2015) CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes. Abdom Imaging 40:2331–2337CrossRef Lubner MG, Stabo N, Lubner SJ, et al. (2015) CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes. Abdom Imaging 40:2331–2337CrossRef
12.
Zurück zum Zitat Rao S-X, Lambregts DM, Schnerr RS, et al. (2016) CT texture analysis in colorectal liver metastases: a better way than size and volume measurements to assess response to chemotherapy? United Eur Gastroenterol J 4:257–263CrossRef Rao S-X, Lambregts DM, Schnerr RS, et al. (2016) CT texture analysis in colorectal liver metastases: a better way than size and volume measurements to assess response to chemotherapy? United Eur Gastroenterol J 4:257–263CrossRef
13.
Zurück zum Zitat Ahn SJ, Kim JH, Park SJ, Han JK (2016) Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis. Eur J Radiol 85:1867–1874CrossRef Ahn SJ, Kim JH, Park SJ, Han JK (2016) Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis. Eur J Radiol 85:1867–1874CrossRef
14.
Zurück zum Zitat Zhang X, Gao X, Liu BJ, et al. (2015) Effective staging of fibrosis by the selected texture features of liver: which one is better, CT or MR imaging? Comput Med Imaging Graph 46:227–236CrossRef Zhang X, Gao X, Liu BJ, et al. (2015) Effective staging of fibrosis by the selected texture features of liver: which one is better, CT or MR imaging? Comput Med Imaging Graph 46:227–236CrossRef
15.
Zurück zum Zitat Ng F, Kozarski R, Ganeshan B, Goh V (2013) Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis? Eur J Radiol 82:342–348CrossRef Ng F, Kozarski R, Ganeshan B, Goh V (2013) Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis? Eur J Radiol 82:342–348CrossRef
16.
Zurück zum Zitat Cui Y, Zhang X-P, Sun Y-S, Tang L, Shen L (2008) Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 248:894–900CrossRef Cui Y, Zhang X-P, Sun Y-S, Tang L, Shen L (2008) Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 248:894–900CrossRef
17.
Zurück zum Zitat Ganeshan B, Goh V, Mandeville HC, et al. (2013) Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. Radiology 266:326–336CrossRef Ganeshan B, Goh V, Mandeville HC, et al. (2013) Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. Radiology 266:326–336CrossRef
18.
Zurück zum Zitat Ng F, Ganeshan B, Kozarski R, Miles KA, Goh V (2013) Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology 266:177–184CrossRef Ng F, Ganeshan B, Kozarski R, Miles KA, Goh V (2013) Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology 266:177–184CrossRef
19.
Zurück zum Zitat Ganeshan B, Panayiotou E, Burnand K, Dizdarevic S, Miles K (2012) Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival. Eur Radiol 22:796–802CrossRef Ganeshan B, Panayiotou E, Burnand K, Dizdarevic S, Miles K (2012) Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival. Eur Radiol 22:796–802CrossRef
20.
Zurück zum Zitat Oh JS, Kang BC, Roh J-L, et al. (2015) Intratumor textural heterogeneity on pretreatment (18)F-FDG PET images predicts response and survival after chemoradiotherapy for hypopharyngeal cancer. Ann Surg Oncol 22:2746–2754CrossRef Oh JS, Kang BC, Roh J-L, et al. (2015) Intratumor textural heterogeneity on pretreatment (18)F-FDG PET images predicts response and survival after chemoradiotherapy for hypopharyngeal cancer. Ann Surg Oncol 22:2746–2754CrossRef
21.
Zurück zum Zitat Liang HY, Huang YQ, Yang ZX, Ying-Ding Zeng MS, Rao SX (2016) Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases. Eur Radiol 26:2009–2018CrossRef Liang HY, Huang YQ, Yang ZX, Ying-Ding Zeng MS, Rao SX (2016) Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases. Eur Radiol 26:2009–2018CrossRef
22.
Zurück zum Zitat Tournigand C, André T, Achille E, et al. (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22:229–237CrossRef Tournigand C, André T, Achille E, et al. (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22:229–237CrossRef
23.
Zurück zum Zitat Colucci G, Gebbia V, Paoletti G, et al. (2005) Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell’Italia Meridionale. J Clin Oncol 23:4866–4875CrossRef Colucci G, Gebbia V, Paoletti G, et al. (2005) Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell’Italia Meridionale. J Clin Oncol 23:4866–4875CrossRef
24.
Zurück zum Zitat Kabbinavar FF, Schulz J, McCleod M, et al. (2005) Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. J Clin Oncol 23:3697–3705CrossRef Kabbinavar FF, Schulz J, McCleod M, et al. (2005) Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. J Clin Oncol 23:3697–3705CrossRef
25.
Zurück zum Zitat Egger ME, Cannon RM, Metzger TL, et al. (2013) Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor. J Am Coll Surg 216:845–857CrossRef Egger ME, Cannon RM, Metzger TL, et al. (2013) Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor. J Am Coll Surg 216:845–857CrossRef
26.
Zurück zum Zitat Chun YS, Vauthey J-N, Boonsirikamchai P, et al. (2009) Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA 302:2338–2344CrossRef Chun YS, Vauthey J-N, Boonsirikamchai P, et al. (2009) Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA 302:2338–2344CrossRef
27.
Zurück zum Zitat Shindoh J, Loyer EM, Kopetz S, et al. (2012) Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol 30:4566–4572CrossRef Shindoh J, Loyer EM, Kopetz S, et al. (2012) Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol 30:4566–4572CrossRef
28.
Zurück zum Zitat Chung WS, Park MS, Shin SJ, et al. (2012) Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria. Am J Roentgenol 199:809–815CrossRef Chung WS, Park MS, Shin SJ, et al. (2012) Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria. Am J Roentgenol 199:809–815CrossRef
Metadaten
Titel
MR texture analysis: potential imaging biomarker for predicting the chemotherapeutic response of patients with colorectal liver metastases
verfasst von
Huan Zhang
Wenhua Li
Feixiang Hu
Yiqun Sun
Tingdan Hu
Tong Tong
Publikationsdatum
02.07.2018
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 1/2019
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1682-1

Weitere Artikel der Ausgabe 1/2019

Abdominal Radiology 1/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.